[ET Net News Agency, 8 September 2026] GENSCRIPT BIO (01548) rose 9.9% to HK$34.06.
It hits an intra-day high of HK$34.1, breaking above the 20-D SMA of HK$31.982, and an intra-day low of HK$31.32. The total shares traded was 23.32 million, with a value of HK$769.91m. The active buy/sell ratio is 60:40, with net buying turnover of HK$145.33m. MACQUARIE CAPITAL accounts for greatest net responsive buying turnover of HK$23.83m, with volume weighted average price of HK$33.128. MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of HK$47.23m, with volume weighted average price of HK$33.243.
Basic Information| Nominal | 34.060 | % Chg | +9.87% |
| High | 34.100 | Low | 31.320 |
| Shares Tr | 23.32m | Turnover | 769.91m |
| 10-D SMA | 34.476 | %H.V | 91.269 |
| 20-D SMA | 31.982 | VWAP | 33.009 |
| 50-D SMA | 22.501 | RSI14 | 62.287 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 60:40, with net buying turnover of HK$145.33m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| GENSCRIPT BIO (01548) | 34.060 | +9.87 |
| INNOVENT BIO (01801) | 100.600 | -0.69 |
| EVEREST MED (01952) | 32.820 | +4.86 |
| XTALPI (02228) | 7.255 | +1.61 |
| WUXI XDC (02268) | 75.850 | +4.55 |
| WUXI BIO (02269) | 49.180 | +1.44 |
| WUXI APPTEC (02359) | 194.300 | +1.36 |
| BEONE MEDICINES (06160) | 211.400 | -1.77 |
| CANSINOBIO (06185) | 29.580 | +3.79 |
| AKESO (09926) | 97.000 | +1.04 |
(ed)
Nominal 
